Discovery & Development

Diseases can affect men and women differently. We must acknowledge and accept that – and then optimize drug development accordingly

Acknowledging the shortcomings in IBD-related clinical trials and a potential holistic approach to overcoming them

Sitting Down With Christian Baber of the Pistoia Alliance

How quantum mechanics and machine learning can be combined to develop new drugs

As incidents of DEG poisoning continue to occur, the IPEC Federation issues a call for companies not to be complacent when it comes to supply chains.

Academia has its appeal for many; for others the real challenges are in industry. Here, IO Biotech CEO Mai-Britt Zocca discusses her own motivations.

Self-propelled nanoparticles can reduce tumors in the bladder by 90 percent

A host of pharma industry experts discuss the increasing use of digital technology in decentralized clinical trials.

Oncology is a tricky sector in which to innovate, but we can start by optimizing existing combination approaches

Looking back on the achievements of Rosalind Franklin